Station 41
Biotechnology Research
Birmingham, Alabama, United States
3 employees
- Employees
- 3
Station 41 Overview
- Headquarters
- Birmingham, Alabama, United States
- Website
- station41.bio
- Industry
- Biotechnology Research
- Employees
- 3
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Station 41
Station 41 is Southern Research’s dynamic commercialization hub located in Birmingham, AL. The name Station 41 holds deep significance—capturing both our organization’s rich history and the vibrant spirit of innovation that drives us forward. The number 41 is a tribute to Southern Research’s founding year in 1941; for more than eight decades, we have been at the forefront of scientific breakthroughs, pushing boundaries, and creating lasting impact. The word “station” is a nod to the pivotal role Birmingham played in the growth of the railroad industry. At Station 41, we embrace the spirit of innovation that has defined Birmingham throughout its history. Just as the city’s trains carried goods and ideas to new destinations, we strive to propel groundbreaking technologies and transformative ideas into the world. We are focused on providing the resources, expertise, and collaborative environment necessary to accelerate innovation and drive commercialization. Our goal is to be a catalyst for progress, enabling our partners to reach new heights of success.
Station 41 Contact Details
- People in AeroLeads
- 1
Station 41 Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Bruce Edward Jones, Phd | President and CEO at Score Pharma |
View
|
Compare Similar Companies to Station 41
BioCryst Pharmaceuticals, Inc.
Biotechnology Research
Discovery Life Sciences
Biotechnology Research
Southern Research
Research Services
HudsonAlpha Institute for Biotechnology
Biotechnology Research
Radyus Research
Biotechnology
Innovation Depot
Civic And Social Organizations
BIO Alabama
Biotechnology
Innovate Alabama
Non-Profit Organizations
Measured Capital
Venture Capital And Private Equity Principals
Arrowpoint Labs
Biotechnology Research